The effect of gender on the 50% effective dose of remimazolam for achieving loss of consciousness
Not Applicable
Completed
- Conditions
- Not Applicable
- Registration Number
- KCT0007951
- Lead Sponsor
- Ajou University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Adult patients aged 19-60 years with ASA score 1 or 2 scheduled for general anesthesia
Exclusion Criteria
BMI > 30 kg/m2
History of allergies to benzodiazepines
History of allergies to opioids
Patients unable to response on verbal command
Use of opioids, alcohol, benzodiazeplines and over-the-counter sleep aids
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gender difference in 50% effective dose of remimazolam for achieving loss of consciousness with remifentanil target-controlled infusion
- Secondary Outcome Measures
Name Time Method ED50, ED95 acheived by isotonic regression, vital signs (blood pressure, heart rate, oxygen saturation), UniCon (ADMS™, Anaesthetic Depth Monitor for Sedation) index, loss of consciousness time